Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by Pandoraon Aug 21, 2024 9:24pm
87 Views
Post# 36191070

RE:RE:RE:RE:New Press Release - Ventripoint Receives Medical Device License from Health Canada to Sell Next Generation, AI-powered, Heart-scanning Technology

RE:RE:RE:RE:New Press Release - Ventripoint Receives Medical Device License from Health Canada to Sell Next Generation, AI-powered, Heart-scanning TechnologyFunny how this guy does nothing but throw rocks. He must be a real peach to know or how would you like to have him as a neighbour or ??

"Faux" is a French word that has crept into our lexicon, because faux in French means "fake." Now if we have the words fake, imitation, and false (all of which are good synonyms), why use faux?"

All I did was take this paragraph verbatim i.e. reading it, from the wording it seems to suggest everything was done at the same time --- and for that he immediately calls me a fake. He sure likes to be the policeman on this board. He would probably like it if SH made us run all of our posts through him to see if they pass his discretion and to judge if they can be posted or not.



"Ventripoint submitted VMS+4.0 for clearance by FDA on May 1, a requirement for significant
software and hardware updates and diagnostic advances. We are also pursuing regulatory
clearance in other key markets such as the E.U., U.K and Canada
to make this newest version of
Ventripoint available to the global community."

So he immediately calls me a fake -- such a nice guy! I believe a word starting with an 'A' might be more appropriate but I won't go there. What a pain in the ---!

I've gone through the news releases and I see two that specifically refer to submitting to the FDA but I do not see one that refers specifically to submitting VMS+4 to HC or EU on a specific date. There might be one but I do not see it in the headings..

Other than that enjoy your day. :-))
<< Previous
Bullboard Posts
Next >>